Mutations in PNPLA6 cause Hereditary Spastic Paraplegia 39 (OMIM #612020), but levodopa-responsive parkinsonism has been reported in association with biallelic mutations, generally with additional clinical features64,65. The gene discussed is PNPLA6; the disease is hereditary spastic paraplegia 39.